Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report
Yuya Kamura, Toshiki Terao, Satoshi Akao, et al.
International Journal of Infectious Diseases (2022) Vol. 117, pp. 322-325
Open Access | Times Cited: 12

Showing 12 citing articles:

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
Withdrawn: A systematic review of autopsy findings in deaths after COVID-19 vaccination
Nicolas Hulscher, Paul Alexander, Richard Amerling, et al.
Forensic Science International (2024), pp. 112115-112115
Open Access | Times Cited: 4
A Severe Case of Rhabdomyolysis Requiring Renal Replacement Therapy Following COVID-19 mRNA Vaccination
Miya Ueda, Kohei Uchimura, Kie Ohkoshi, et al.
Internal Medicine (2025)
Open Access
Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report
Kathleen Claes, Inge Geerts, Wim Lemahieu, et al.
American Journal of Kidney Diseases (2022) Vol. 81, Iss. 3, pp. 364-367
Open Access | Times Cited: 14
A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review
Maria Sheka, Yann Coattrenec, Kuntheavy Ing Lorenzini, et al.
Clinical Case Reports (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 6
Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination
Motoya Kimura, Jun‐ichi Niwa, Manabu Doyu
Vaccines (2022) Vol. 10, Iss. 6, pp. 935-935
Open Access | Times Cited: 9
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report
Ryo Kaimori, Haruto Nishida, Tomohisa Uchida, et al.
Thrombosis Journal (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-Series
É. Liozon, Matthieu Filloux, Simon Parreau, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7484-7484
Open Access | Times Cited: 8
A severe case of papulovesicular exthanthema with rhabdomyolysis after corona virus disease 2019 heterologous booster vaccination
Atsunori Baba, Maki Yoshimitsu, Takuro Kanekura, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 12
Open Access | Times Cited: 3
Thrombotic Microangiopathy Post-COVID-19 Vaccination
Rahaf Salem, Ibrahim Al Mulla, Noure Alhouda, et al.
Cureus (2024)
Open Access
Anticoagulants/eculizumab/elasomeran

Reactions Weekly (2022) Vol. 1901, Iss. 1, pp. 66-66
Closed Access
Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
Josef Finsterer, Fulvio A. Scorza
International Journal of Infectious Diseases (2022) Vol. 122, pp. 443-443
Open Access
Page 1

Scroll to top